Details for Patent: 11,304,951
✉ Email this page to a colleague
Which drugs does patent 11,304,951 protect, and when does it expire?
Patent 11,304,951 protects INVEGA HAFYERA and is included in one NDA.
This patent has ten patent family members in ten countries.
Summary for Patent: 11,304,951
| Title: | Dosing regimens associated with extended release paliperidone injectable formulations |
| Abstract: | The present invention provides a method of treating patients with long acting injectable paliperidone palmitate formulations. |
| Inventor(s): | Gopal; Srihari (Belle Mead, NJ), Venkatasubramanian; Raja (Newtown, PA), T'Jollyn; Huybrecht (Ghent, BE) |
| Assignee: | Janssen Pharmaceutica NV (Beerse, BE) |
| Application Number: | 17/314,330 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 11,304,951
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Janssen Pharms | INVEGA HAFYERA | paliperidone palmitate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207946-005 | Aug 30, 2021 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | REINITIATION OF SCHIZOPHRENIA TREATMENT WHEREIN MORE THAN 6 MONTHS 3 WEEKS BUT LESS THAN 8 MONTHS HAVE ELAPSED SINCE THE LAST DOSE | ⤷ Try a Trial | ||||
| Janssen Pharms | INVEGA HAFYERA | paliperidone palmitate | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207946-006 | Aug 30, 2021 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | REINITIATION OF SCHIZOPHRENIA TREATMENT WHEREIN MORE THAN 6 MONTHS 3 WEEKS BUT LESS THAN 8 MONTHS HAVE ELAPSED SINCE THE LAST DOSE | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,304,951
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2021386450 | ⤷ Try a Trial | |||
| Canada | 3203566 | ⤷ Try a Trial | |||
| China | 116583270 | ⤷ Try a Trial | |||
| European Patent Office | 4025188 | ⤷ Try a Trial | |||
| Finland | 4025188 | ⤷ Try a Trial | |||
| Israel | 303253 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
